MSBT - Efficacy Study of CytoSorb Hemoperfusion Device on IL-6 Removal in ARDS/ALI Patients With Sepsis This study is currently recruiting participants http://clinicaltrials.gov/ct2/show/NCT00559130
All shareholders of MSBT should view this presentation to know what it is you own:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.